|
Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru
|
Llanos-Cuentas, A.; Tulliano, G.; Araujo-Castillo, R.; Miranda-Verastegui, C.; Santamaria-Castrellon, G.; Ramirez, L.; Lazo, M.; De Doncker, S.; Boelaert, M.; Robays, J.; Dujardin, J. C.; Arevalo, J.; Chappuis, F.
|
Clinical Infectious Diseases |
2008
|
Article
|
|
Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis
|
Arevalo, J.; Ramirez, L.; Adaui, V.; Zimic, M.; Tulliano, G.; Miranda-Ver stegui, C.; Lazo, M.; Loayza-Muro, R.; De Doncker, S.; Maurer, A.; Chappuis, F.; Dujardin, J. C.; Llanos-Cuentas, A.
|
Journal of Infectious Diseases |
2007
|
Article
|